Work

Supplemental Figure 1 from Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 1 PDF file 151K, Photomicrograph. IGF-2 circumvents CP01-B02 antibody in vivo

DOI: 10.1158/1078-0432.22452551

Authors: Hemant K. Bid, Cheryl A. London, Jin Gao, Haihong Zhong, Robert E. Hollingsworth, Soledad Fernandez, Xiaokui Mo, Peter J. Houghton

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361883638

Cites:

Cited by:

Related to: 10